Biogen Inc. financial data

Symbol
BIIB on Nasdaq
Location
225 Binney Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 185 % +1.93%
Quick Ratio 53.3 % -19.2%
Debt-to-equity 82.1 % -17.1%
Return On Equity 9.25 % -10.8%
Return On Assets 5.66 % -4.87%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 147M shares +0.68%
Common Stock, Shares, Outstanding 146M shares +0.62%
Entity Public Float 33.7B USD -18.2%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 147M shares +0.62%
Weighted Average Number of Shares Outstanding, Diluted 147M shares +0.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10.1B USD +4.77%
Costs and Expenses 8.16B USD +5.98%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 557M USD +23.6%
Income Tax Expense (Benefit) 296M USD +1.3%
Net Income (Loss) Attributable to Parent 1.61B USD -0.42%
Earnings Per Share, Basic 10 USD/shares -1.08%
Earnings Per Share, Diluted 10 USD/shares -0.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 1.4B USD -15.6%
Inventory, Net 2.21B USD -10.5%
Other Assets, Current 917M USD +36%
Assets, Current 8.94B USD +30.8%
Deferred Income Tax Assets, Net 312M USD -67.8%
Property, Plant and Equipment, Net 3.08B USD -4.21%
Operating Lease, Right-of-Use Asset 331M USD -13.1%
Intangible Assets, Net (Excluding Goodwill) 9.33B USD -4.83%
Goodwill 6.49B USD +0.08%
Other Assets, Noncurrent 730M USD +15.6%
Assets 29.2B USD +3.16%
Accounts Payable, Current 413M USD -2.27%
Employee-related Liabilities, Current 311M USD +7.62%
Liabilities, Current 3.29B USD -39.4%
Accrued Income Taxes, Noncurrent 165M USD +1.67%
Deferred Income Tax Liabilities, Net 358M USD -59.4%
Operating Lease, Liability, Noncurrent 305M USD -14.6%
Other Liabilities, Noncurrent 762M USD +2.38%
Liabilities 11B USD -7.98%
Accumulated Other Comprehensive Income (Loss), Net of Tax -215M USD -47.4%
Retained Earnings (Accumulated Deficit) 20.6B USD +8.47%
Stockholders' Equity Attributable to Parent 14.8B USD +10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 18.2B USD +11.3%
Liabilities and Equity 29.2B USD +3.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 259M USD -53.1%
Net Cash Provided by (Used in) Financing Activities -23M USD +94.8%
Net Cash Provided by (Used in) Investing Activities -47.3M USD +28.3%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 170M shares +0.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.86B USD +127%
Deferred Tax Assets, Valuation Allowance 1.01B USD -20.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 421M USD -14.2%
Depreciation 278M USD +0.07%
Payments to Acquire Property, Plant, and Equipment 37.1M USD -19.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.54B USD -5.49%
Lessee, Operating Lease, Liability, to be Paid 505M USD -14.7%
Property, Plant and Equipment, Gross 5.85B USD +2.45%
Operating Lease, Liability, Current 86.4M USD -4.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88.5M USD -7.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 103M USD -2.64%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -27.8M USD -170%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 83.8M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 88.3M USD +5.75%
Deferred Tax Assets, Operating Loss Carryforwards 1.36B USD -20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 8M shares 0%
Unrecognized Tax Benefits 186M USD +7.44%
Lessee, Operating Lease, Liability, to be Paid, Year Four 50.2M USD -41.7%
Additional Paid in Capital 798M USD +63.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 136M USD +23.3%
Depreciation, Depletion and Amortization 183M USD +24.2%
Deferred Tax Assets, Net of Valuation Allowance 2.93B USD +0.02%
Share-based Payment Arrangement, Expense -302M USD -9.88%
Interest Expense 260M USD -0.69%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%